155366-02-2 Usage
Structure
Spiroketone with a dioxaspirodecene framework
The compound features a spiro carbon atom connecting a six-membered oxygen heterocycle to a seven-membered carbon ring.
3. 3,5-Difluorophenyl substituent
A phenyl group with two fluorine atoms attached at the 3rd and 5th positions, which is attached to the spiro carbon atom.
Potential applications
Pharmaceutical and materials science
The unique chemical properties of the compound make it a candidate for further research in the development of novel drugs or materials.
Further research and development
Possible discovery of new drugs or materials
Ongoing studies and development of this compound may lead to the identification of new substances with specific properties and applications.
Chemical properties
Influenced by the 3,5-difluorophenyl substituent
The presence of the difluorophenyl group on the spiro carbon atom imparts unique chemical properties to the compound, which can be exploited in various applications.
Stability
Unknown, but potentially influenced by the dioxaspirodecene structure and the 3,5-difluorophenyl substituent
The stability of the compound may be affected by the presence of the oxygen heterocycle and the fluorinated phenyl group, which could impact its reactivity and shelf life.
Solubility
Unknown, but may be influenced by the polar oxygen atoms and the fluorinated phenyl group
The solubility of the compound in various solvents is not provided, but it can be inferred that the presence of polar oxygen atoms and the electronegative fluorine atoms may affect its solubility profile.
Reactivity
Unknown, but may be influenced by the spiro carbon atom and the dioxaspirodecene structure
The reactivity of the compound is not specified, but the presence of the spiro carbon atom and the dioxaspirodecene framework may contribute to its reactivity with other chemical species.
Synthesis
Not provided in the material, but likely involves the formation of the dioxaspirodecene framework and subsequent introduction of the 3,5-difluorophenyl group
The synthesis of the compound is not described in the material, but it can be inferred that the process involves the formation of the spiro carbon atom and the dioxaspirodecene structure, followed by the introduction of the 3,5-difluorophenyl substituent.
Check Digit Verification of cas no
The CAS Registry Mumber 155366-02-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,3,6 and 6 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 155366-02:
(8*1)+(7*5)+(6*5)+(5*3)+(4*6)+(3*6)+(2*0)+(1*2)=132
132 % 10 = 2
So 155366-02-2 is a valid CAS Registry Number.
155366-02-2Relevant articles and documents
Electro-Olefination—A Catalyst Free Stereoconvergent Strategy for the Functionalization of Alkenes
Baumann, Andreas N.,Dechent, Jonas,Didier, Dorian,Jagau, Thomas C.,Müller, Nicolas,Music, Arif
, (2020/07/04)
Conventional methods carrying out C(sp2)?C(sp2) bond formations are typically mediated by transition-metal-based catalysts. Herein, we conceptualize a complementary avenue to access such bonds by exploiting the potential of electrochemistry in combination with organoboron chemistry. We demonstrate a transition metal catalyst-free electrocoupling between (hetero)aryls and alkenes through readily available alkenyl-tri(hetero)aryl borate salts (ATBs) in a stereoconvergent fashion. This unprecedented transformation was investigated theoretically and experimentally and led to a library of functionalized alkenes. The concept was then carried further and applied to the synthesis of the natural product pinosylvin and the derivatization of the steroidal dehydroepiandrosterone (DHEA) scaffold.
NOVEL 5 or 8-SUBSTITUTED IMIDAZO [1, 5-a] PYRIDINES AS SELECTIVE INHIBITORS OF INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES
-
Paragraph 0801; 0802, (2018/04/20)
Disclosed herein are 5 or 8-substituted imidazo [1, 5-a] pyridines and pharmaceutical compositions comprising at least one such 5 or 8-substituted imidazo [1, 5-a] pyridines, processes for the preparation thereof, and the use thereof in therapy. Disclosed herein are certain 5 or 8-substituted imidazo [1, 5-a] pyridines that can be useful for inhibiting indoleamine 2, 3-dioxygenase and/or tryptophane 2, 3-dioxygenase and for treating diseases or disorders mediated thereby.
LIQUID CRYSTALLINE COMPOUND HAVING DIFLUOROMETHYLENEOXY GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT
-
Paragraph 0158; 0160, (2018/04/03)
PROBLEM TO BE SOLVED: To provide a liquid crystalline compound having at least one sufficient property in physical properties such as high stability to heat or light, a high clear point (or high maximum temperature), a low minimum temperature of a liquid
